Oncosil Medical Ltd operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Oncosil Medical Ltd with three other
companies in this sector in Australia:
Immutep Ltd
(2017
sales of 4.22 million Australian Dollars [US$3.28 million]
of which 98%
was Cancer Immunotherapy),
Starpharma Holdings Limited
(3.65 million Australian Dollars [US$2.84 million]
of which 100%
was Dendritic), and
Dorsavi Ltd
(3.87 million Australian Dollars [US$3.01 million]
of which 53%
was Australia).
Sales Analysis.